BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33614866)

  • 1. Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors.
    Fitzgerald JM; Chesney SA; Lee TS; Brasel K; Larson CL; Hillard CJ; deRoon-Cassini TA
    Neurobiol Stress; 2021 May; 14():100304. PubMed ID: 33614866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.
    Carey CE; Agrawal A; Zhang B; Conley ED; Degenhardt L; Heath AC; Li D; Lynskey MT; Martin NG; Montgomery GW; Wang T; Bierut LJ; Hariri AR; Nelson EC; Bogdan R
    J Abnorm Psychol; 2015 Nov; 124(4):860-77. PubMed ID: 26595473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
    Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
    Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression.
    Kirkedal C; Elfving B; Müller HK; Moreira FA; Bindila L; Lutz B; Wegener G; Liebenberg N
    Neurochem Int; 2019 May; 125():7-15. PubMed ID: 30716357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.
    Gray JM; Wilson CD; Lee TT; Pittman QJ; Deussing JM; Hillard CJ; McEwen BS; Schulkin J; Karatsoreos IN; Patel S; Hill MN
    Psychoneuroendocrinology; 2016 Apr; 66():151-8. PubMed ID: 26821211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of interferon-alpha treatment on AEA and 2-AG levels.
    Zajkowska Z; Borsini A; Nikkheslat N; Russell A; Romano GF; Tomassi S; Hepgul N; Forton D; Agarwal K; Hotopf M; Mondelli V; Zunszain P; Pariante CM
    Brain Behav Immun; 2020 Nov; 90():248-258. PubMed ID: 32860939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinergic modulation of central serotonergic activity in healthy human volunteers.
    Emons B; Arning L; Makulla VE; Suchy MT; Tsikas D; Lücke T; Epplen JT; Juckel G; Roser P
    Ann Gen Psychiatry; 2023 Mar; 22(1):11. PubMed ID: 36932421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats.
    Lee TT; Hill MN; Hillard CJ; Gorzalka BB
    Neuropharmacology; 2015 Dec; 99():89-97. PubMed ID: 26192544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-autonomous and differential endocannabinoid signaling impacts the development of presynaptic retinal ganglion cell axon connectivity
    Del Rio R; Serrano RG; Gomez E; Martinez JC; Edward MA; Santos RA; Diaz KS; Cohen-Cory S
    Front Synaptic Neurosci; 2023; 15():1176864. PubMed ID: 37252636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of endocannabinoids in rapid suppression of stress responses by glucocorticoids in neonates.
    Buwembo A; Long H; Walker CD
    Neuroscience; 2013 Sep; 249():154-61. PubMed ID: 23131711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterol carrier protein-2: binding protein for endocannabinoids.
    Liedhegner ES; Vogt CD; Sem DS; Cunningham CW; Hillard CJ
    Mol Neurobiol; 2014 Aug; 50(1):149-58. PubMed ID: 24510313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating endocannabinoids and psychological outcomes in women with PTSD.
    Botsford C; Brellenthin AG; Cisler JM; Hillard CJ; Koltyn KF; Crombie KM
    J Anxiety Disord; 2023 Jan; 93():102656. PubMed ID: 36469982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating endocannabinoid concentrations in grieving adults.
    Harfmann EJ; McAuliffe TL; Larson ER; Claesges SA; Sauber G; Hillard CJ; Goveas JS
    Psychoneuroendocrinology; 2020 Oct; 120():104801. PubMed ID: 32682172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.
    Segev A; Korem N; Mizrachi Zer-Aviv T; Abush H; Lange R; Sauber G; Hillard CJ; Akirav I
    Neuropsychopharmacology; 2018 Sep; 43(10):2017-2027. PubMed ID: 29977073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system.
    Shinjyo N; Piscitelli F; Verde R; Di Marzo V
    J Neurosci Res; 2013 Jul; 91(7):943-53. PubMed ID: 23633391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.
    Saario SM; Laitinen JT
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):287-93. PubMed ID: 17910610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Characterization of the Endocannabinoid Sensor GRAB
    Singh S; Sarroza D; English A; McGrory M; Dong A; Zweifel L; Land BB; Li Y; Bruchas MR; Stella N
    Cannabis Cannabinoid Res; 2023 Dec; ():. PubMed ID: 38064488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.